ARMP Stock Analysis: Buy, Sell, or Hold?
ARMP - Armata Pharmaceuticals, Inc. Common Stock
$7.75
0.01 (0.13%)
▲
5d:
+17.6%
30d:
+18.14%
90d:
+57.84%
HOLD
MODERATE Confidence
Last Updated: February 3, 2026
Earnings: Mar 19, 2026
Get Alerted When ARMP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called ARMP this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: ARMP is 9.6% above fair value ($7.07). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: ARMP is 9.6% above fair value ($7.07). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: ARMP is currently trading at $7.75, which is considered extended relative to its 30-day fair value range of $5.97 to $7.07.
Technical Outlook: Technically, ARMP is in a strong uptrend. The price is approaching resistance at $7.80. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ARMP has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $12.00 (+54.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ARMP is in a strong uptrend. The price is approaching resistance at $7.80. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ARMP has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $12.00 (+54.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$5.97 -
$7.07
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price extended above range (+9.6% above fair value)
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 54.8% below Wall St target ($12.00)
- CAUTION: Extended 9.6% above fair value - wait for pullback
Fair Price Analysis
30-Day Fair Range
$5.97 -
$7.07
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$1.38
(17.8%)
Support & Resistance Levels
Support Level
$5.75
Resistance Level
$7.80
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-7.11
Wall Street Target
$12.00
(+54.8%)
Revenue Growth (YoY)
-61.0%
Last updated: February 03, 2026 8:30 PM ET
Data refreshes hourly during market hours. Next update: 9:30 PM
Data refreshes hourly during market hours. Next update: 9:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARMP showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 56 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 59 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$34 | 57 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 60 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 62 BUY |
